Last edition
News about "NRx Pharmaceuticals "
NRx Pharmaceuticals Advances NRX-100 NDA Submission to FDA for Suicidal Depression Treatment
NRX-100 was initially granted Fast Track Designation in 2017 for use in combination with NRX-101 (D-cycloserine/lurasidone) for the treatment of suicidal bipolar depression.
NRx Pharmaceuticals | 01/01/2025 | By Abha
NRx Pharmaceuticals Welcomes Michael Abrams as Chief Financial Officer
Abrams succeeds Interim-CFO Richard Narido, who will continue to support the Company's financial function and other projects.
NRx Pharmaceuticals | 19/11/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy